Einstein Researcher Receives $100,000 Grant For Lung Cancer Research
Dr. McDaid's grant is part of $1.2 million in total funding that Joan's Legacy is presenting to researchers at nationally recognized institutions during 2007, including grants made in collaboration with other research-focused lung cancer nonprofits, such as the LUNGevity Foundation. The purpose of the grants is to support innovative research projects focused on lung cancer, which, with 160,000 deaths per year, is the number one cancer killer in the United States.
In studying the lung cancer genotypes, Dr. McDaid will focus on mutations in two proteins -B- RAF and K-RAS - to determine their response to targeted therapy. She has been a member of the Einstein faculty since 2001 and a member of the Albert Einstein Cancer Center since 2005, where she colleagues hold a patent for treating newly formed tumors using combination chemotherapy.
Joan's Legacy is named for Joan Scarangello, a writer and nonsmoker who died at age 47 after a valiant and nine-month fight with lung cancer. The organization is committed to fighting lung cancer by searching for a cure and focusing greater attention on the world's leading cancer killer, including in neversmokers. In just five years, Joan's Legacy has funded over $3.6 million in new and cutting-edge lung cancer research. "In 2007, we received a record-breaking 65 proposals for funding," said Joan's Legacy President Mary Ann Tighe. "This overwhelming response demonstrates how funding availability can stimulate the scientific community to focus efforts on this often neglected disease with its resultingly low survival rates."
Albert Einstein College of Medicine
Einstein a primit Cercetãtor $ 100,000 Grant Pentru Lung Cancer Research - Einstein Researcher Receives $100,000 Grant For Lung Cancer Research - articole medicale engleza - startsanatate